
MEA Medical Tourism Market
Get a free sample of this report
Form submitted successfully!
Error submitting form. Please try again.
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!

Request Sectional Data
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Heavy infrastructure investments in hospitals, medical cities, and specialty clinics, and the development of health tourism-focused infrastructure, including hotels, recovery resorts, etc., continue to be the key economic catalyst in the industry's growth. For example, the World Bank analysts have repeatedly highlighted persistent affordability gaps and their impact on household conditions that push consumers toward price-sensitive destinations. At the same time, destination hospitals have scaled to international quality norms, often through JCI accreditation, which improves insurer acceptance and patient confidence.
The market has increased from USD 796.4 Million in 2022 and reached USD 2.3 billion in 2024, with the historic growth rate of 70.5%. Patients searching for high-quality yet affordable medical care are being attracted by Middle Eastern and African nations such as the UAE, Saudi Arabia, South Africa, Egypt, and Jordan that offer high-end technology at a competitive price structure versus Western countries. High-quality and affordable medical care with proven clinical outcomes makes these countries a preferable option for many patients going for cosmetic, dental, orthopedic, fertility, and oncology surgery. There is an observable trend in the increasing number of patients traveling to hubs (e.g., Cairo, Abu Dhabi, Dubai) to take advantage of affordability combined with reliable quality of care standards. This further highlights evidence of the competitiveness of the MEA region as patients continue to find price-driven opportunities to receive the care they require, and MEA countries are continually improving their capacity to accommodate the growing demand for cross-border care.
Further, medical treatments in the Middle East and Africa (MEA) are becoming more advanced with the growing number of hospitals and clinical facilities providing specialty services. Major cities have been emerging as large regional service centers. For example, cities such as Dubai, Abu Dhabi, Riyadh, and Amman, among others, have become key centers for medical services because of the growth of new surgical technologies and the availability of medical and surgical expertise. Furthermore, as the MEA facilities continue to increase their offerings of robotic surgery and minimally invasive procedures as well as complex therapeutic services, the region may position itself as a notable player among the world's best destinations for medical tourists seeking advanced medical treatment options.
Moreover, the MEA region faces a rapidly rising burden of chronic illnesses, cardiovascular disease, diabetes, cancer, and respiratory disorders due to aging populations, urban lifestyles, and shifting demographics. For example, Saudi Arabia has a very high cardiovascular disease (CVD) mortality of around 330 to 380 per 100,000. This is significantly higher than the estimates for Western countries, which range between 80 and 199 per 100,000. Thus, the growing chronic patient population is anticipated to fuel the regional industry growth over the forecast timeline.
In medical tourism, the patient travels abroad for various medical treatments covering everything from preventive health treatments and elective surgeries to complex medical procedures and remote rehabilitation services. This practice allows people to receive quality healthcare at lower costs with a minimum waiting period, enhancing the patient’s treatment experience.
The Middle East and Africa medical tourism market was valued at USD 3.2 billion in 2025. The market is expected to grow from USD 3.8 billion in 2026 to USD 9.4 billion in 2035, at a CAGR of 10.6% during the forecast period, according to the latest report published by Global Market Insights Inc.
Surge in medical infrastructure investment, increasing demand for specialty and advanced procedures, growing integration of wellness and medical tourism, and rise of international accreditation and quality standards are among the key trends shaping the market growth.

In 2022, the market was valued at USD 0.8 billion and grew to USD 1.5 billion in 2023, reaching USD 2.3 billion by 2024. Rising demand for personalized and precision treatments along with growing prevalence of chronic diseases are among the key variables contributing to industry growth.
Based on application, the market is segmented into cosmetic surgery, cardiovascular surgery, orthopedic surgery, oncology treatment, dental surgery, bariatric surgery, fertility treatment, and other applications. The cosmetic surgery segment accounted for a leading share of 20.4% in 2025. Growing focus of younger adults on aesthetics is a key factor fueling the segmental growth. The segment is expected to reach USD 2.3 billion by 2035, growing at a CAGR of 12.7% during the forecast period.

Based on end use, the MEA medical tourism market is segmented into specialty clinics, hospitals and other end users. The hospitals segment accounted for the leading market share of 53.3% in 2025.

The UAE medical tourism market was valued at USD 196.8 million and USD 362.9 million in 2022 and 2023, respectively. In 2025 the market size was valued at USD 780.1 million from USD 566.4 million in 2024. Availability of highly skilled professionals for range of treatments in the country is projected to fuel the market growth.
Jordan accounted for a significant share of the MEA medical tourism market and was valued at USD 538.9 million in 2025.
The Saudi Arabia medical tourism market accounted for a notable share of the market and was valued at USD 325.9 million in 2025.
The MEA market is shaped by a mix of high‑performing regional hubs, each competing through infrastructure strength, accreditation, specialization, and service quality. The ability to deliver a whole range of health and wellness services within an overall tourist experience in the UAE is due to their high standards of hospital care, internationally accredited hospitals, and short waiting lists that allow for a seamless experience in the country.
Additionally, Saudi Arabia's transformation from a provider of medical tourism services into a recipient of medical tourism services is attributed majorly to the kingdom's considerable investment in specialized hospitals and medical cities. The country's other Vision 2030 reforms also provide improved regulatory support, enhanced quality standards, and better organized services, which may enable Saudi Arabia to continue to be a key player in the regional industry.
Further, Jordan maintains a strong competitive presence due to its reputation for high‑quality physicians, cost‑effective care, and strong demand from GCC and regional patients. Further, South Africa, Egypt, and several other countries compete through affordability, established clinical expertise, and diverse specialty offerings, especially in cosmetic, dental, and orthopedic procedures. Together, these countries create a dynamic, multi‑hub competitive environment that continues to elevate MEA’s position as a growing global medical tourism destination.
A few of the prominent players operating in the MEA medical tourism industry include:
Focuses on leveraging Dubai’s medical tourism framework (DXH), investing in advanced technologies, expanding international partnerships, and offering personalized, telemedicine‑supported patient pathways to attract global patients seeking premium, innovative care.
Strengthens global presence through comprehensive international patient services, advanced treatment planning, and cross‑border collaborations while promoting clinical excellence, innovation, and humanitarian outreach to position itself as a global referral destination.
Builds competitive advantage through strong accreditation, advanced technology investments, high‑quality surgical outcomes, and comprehensive care packages, serving diverse international patients with culturally aligned, cost‑efficient, and trusted medical services.
| Key Takeaway | Details |
|---|---|
| Market Size & Growth | |
| Base Year | 2025 |
| Market Size in 2025 | USD 3.2 Billion |
| Market Size in 2026 | USD 3.8 Billion |
| Forecast Period 2026-2035 CAGR | 10.6% |
| Market Size in 2035 | USD 9.4 Billion |
| Key Market Trends | |
| Drivers | Impact |
| Rising demand for affordable and high‑quality medical care within MEA region | Growing patient inflow into UAE, South Africa, Egypt, and Jordan as travelers seek cost‑effective, reliable treatment, boosting regional medical tourism volumes |
| Expansion of advanced procedures | High‑complexity treatments in cardiology, oncology, orthopedics, and fertility attract regional patients seeking specialized care unavailable or expensive at home |
| Availability of internationally accredited facilities and supportive government initiatives | Internationally accredited hospitals and government‑backed reforms in UAE and Saudi Arabia enhance patient trust and strengthen MEA’s reputation for safe, high‑quality care |
| Increasing prevalence of chronic diseases | Rising cardiovascular, cancer, and diabetes cases drive cross‑border travel for advanced specialist care within MEA’s expanding treatment hubs |
| Pitfalls & Challenges | Impact |
| Issue with patient follow-up and post-surgery complications | Inconsistent post‑treatment coordination across MEA facilities increases risk of care gaps, reducing patient confidence and complicating long‑term recovery |
| Opportunities: | Impact |
| Growth of wellness and integrative medicine packages | Expansion of wellness‑driven recovery services will position MEA destinations as holistic healing hubs, boosting patient experience and diversifying medical tourism offerings |
| Rise of telemedicine | Teleconsultations and remote treatment planning will streamline international patient pathways, reduce pre‑travel barriers, and widen MEA hospitals’ global reach |
| Market Leaders (2025) | |
| Top Players |
|
| Competitive Edge |
|
| Regional Insights | |
| Largest Market | UAE |
| Fastest growing market | UAE |
| Emerging countries | Saudi Arabia, Israel, Egypt |
| Future outlook |
|
The MEA medical tourism market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:
The above information is provided for the following countries:
The market size was USD 3.2 billion in 2025, with a CAGR of 10.6% expected through 2035, driven by internationally accredited facilities, government initiatives, and rising demand for affordable, high-quality care.
The MEA medical tourism market is expected to reach USD 9.4 billion by 2035, propelled by the expansion of advanced procedures and increasing prevalence of chronic diseases.
The market size is projected to reach USD 3.8 billion in 2026.
The hospitals segment held 53.3% market share and generated USD 1.7 billion in 2025, supported by investments in advanced healthcare services and international accreditations.
The cosmetic surgery segment is projected to grow at a CAGR of 12.7% till 2035, reaching USD 2.3 billion, driven by rising focus on aesthetics and affordability in the MEA region.
The UAE leads the market, with a valuation of USD 780.1 million in 2025, supported by excellent healthcare infrastructure, government strategies, and advanced diagnostic technologies.
Key players include American Hospital Dubai, Sheba Medical Center, The Specialty Hospital, Saudi German Hospital, and Cleveland Clinic Abu Dhabi.
Related Reports
Explore Our Licensing Options: